Heart Disease Trial, Recruiting (NCT07209098)

Heart Disease Trial, Recruiting NCT07209098 Sponsor: Impulse Dynamics Condition: Heart Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07209098 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Heart Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been continuously recorded in the relevant database for at least one year before the study start date
People aged 18 or older, who would be placed in either the treatment group or the comparison group
People who have been diagnosed with a moderate-to-severe level of heart failure (classified as NYHA Class III, meaning daily activities cause noticeable symptoms)
People who are not currently receiving a therapy called cardiac resynchronisation therapy (CRT), which is a type of electrical treatment for the heart
People whose heart pumping strength (called ejection fraction) falls between 25% and 45%
People who continue to have heart failure symptoms even after at least 3 months of the best available standard heart failure medications, as assessed by a heart care team before a specific device is implanted

Who may not be able to join:

People who have previously had a heart transplant
People who have a mechanical (artificial) valve in the tricuspid part of the heart
People who have a mechanical heart pump device implanted, known as a left ventricular assist device (LVAD)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 7 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 856-642-9933

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07209098

Sponsor: Impulse Dynamics

Phase: Not Applicable

Status: Recruiting

Condition: Heart Disease

Trial contact: 856-642-9933

More information: https://clinicaltrials.gov/study/NCT07209098

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been continuously recorded in the relevant database for at least one year before the study start date
People aged 18 or older, who would be placed in either the treatment group or the comparison group
People who have been diagnosed with a moderate-to-severe level of heart failure (classified as NYHA Class III, meaning daily activities cause noticeable symptoms)
People who are not currently receiving a therapy called cardiac resynchronisation therapy (CRT), which is a type of electrical treatment for the heart
People whose heart pumping strength (called ejection fraction) falls between 25% and 45%
People who continue to have heart failure symptoms even after at least 3 months of the best available standard heart failure medications, as assessed by a heart care team before a specific device is implanted

Who may not be able to join:

People who have previously had a heart transplant
People who have a mechanical (artificial) valve in the tricuspid part of the heart
People who have a mechanical heart pump device implanted, known as a left ventricular assist device (LVAD)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 7 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Impulse Dynamics

Registry

ClinicalTrials.gov

Start date

18 November 2025

Est. completion

1 October 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Time to first heart failure hospitalization or all-cause death

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov